Methamphetamine dependence

Search with Google Search with Bing
Information
Disease name
Methamphetamine dependence
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04907357 Active, not recruiting N/A rTMS for Stimulant Use Disorders February 4, 2022 July 2024
NCT00284206 Completed Phase 2 A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence January 2006 August 2007
NCT00332605 Completed Phase 2 N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence June 2006 January 2010
NCT00469508 Completed Phase 2 Modafinil vs Placebo for the Treatment of Methamphetamine Dependence April 2007 January 2009
NCT01860807 Completed Phase 2 Trial of Ibudilast for Methamphetamine Dependence July 2013 December 31, 2017
NCT01354470 Completed Phase 2 A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence October 2011
NCT01359930 Completed Phase 1 Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study August 2011 June 2012
NCT01365819 Completed Phase 2 Varenicline for Methamphetamine Dependence February 2012 August 2014
NCT01377662 Completed Phase 2 PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND) August 2011 May 2013
NCT01557569 Completed Phase 1/Phase 2 Clinical Efficacy of Atomoxetine for Methamphetamine Dependence April 2012 July 2015
NCT01571167 Completed Phase 1 Varenicline as a Treatment for Methamphetamine Dependence January 2011 February 2012
NCT01577797 Completed Phase 1 A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence April 2012 July 2013
NCT01685463 Completed N/A Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving September 2008 September 2014
NCT01822730 Completed Phase 4 A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis February 2013 May 2014
NCT01825928 Completed N/A An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence February 2013 July 2014
NCT01843205 Completed Phase 1 Buspirone as a Candidate Medication for Methamphetamine Abuse April 2013 March 2017
NCT00227123 Completed N/A A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence October 2002 November 2006
NCT01967381 Completed Early Phase 1 Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse October 2013 September 2018
NCT02034201 Completed Phase 1 Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence February 2014 May 19, 2016
NCT02058966 Completed Early Phase 1 Pilot Study of Entacapone for Methamphetamine Abuse June 2014 June 2016
NCT00520286 Completed Phase 2 Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence December 2007 March 2010
NCT00569374 Completed Phase 2 Safety and Tolerability of Modafinil for Methamphetamine Dependence September 2007
NCT00603434 Completed Phase 1 Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH) January 2008 March 2009
NCT00653263 Completed Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study August 2006 August 2008
NCT00687713 Completed Phase 2 Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence May 2008 May 2011
NCT00731133 Completed Phase 1/Phase 2 Open-Label Disulfiram for Methamphetamine Dependence August 2008 September 2010
NCT00751023 Completed Phase 4 Effects of Modafinil in Methamphetamine Dependence February 2009 July 2010
NCT00833443 Completed Phase 2 Study of Medical Treatment for Methamphetamine Addiction January 2009 July 2013
NCT00882037 Completed Risk and Protective Factors for Rural Methamphetamine Dependence December 12, 2008 December 15, 2010
NCT00950352 Completed Phase 3 Citicoline Treatment of Methamphetamine Dependence January 2010 December 2012
NCT00984360 Completed Phase 2 Study of Naltrexone for Methamphetamine Addiction September 2009 September 2012
NCT01007539 Completed Phase 3 Efficacy and Safety of CDP-choline in Patients With Methamphetamine Dependence November 2009 January 2012
NCT01011829 Completed Phase 2 Varenicline vs Placebo for the Treatment of Methamphetamine Dependence November 2009 May 2010
NCT01062451 Completed Phase 1 An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence May 2009 November 20, 2013
NCT01063205 Completed Phase 1 NAC as a Potential Treatment for Methamphetamine Dependence March 2010 July 2011
NCT01071356 Completed Phase 2 Intensive Motivational Interviewing for Methamphetamine Dependence February 2009 October 2012
NCT01073319 Completed Phase 1 Rivastigmine as a Treatment for Methamphetamine Dependence July 2009 July 2010
NCT01077024 Completed Phase 3 Smoking-Cessation and Stimulant Treatment (S-CAST) February 2010 August 2012
NCT01215929 Completed Phase 2 Studying Amphetamine Withdrawal in Humans October 2009 May 2014
NCT02568878 Recruiting Phase 3 Creatine for Depressed Male and Female Methamphetamine Users November 2015 May 2017
NCT00730522 Terminated Phase 2 Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence July 2008 November 2009
NCT00567866 Terminated Early Phase 1 Methamphetamine-Quetiapine Interactions in Humans January 2008 September 2009
NCT00859573 Terminated Phase 2 Modafinil for Methamphetamine Dependence April 2009 January 2010
NCT01813643 Terminated Phase 4 A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis July 2012 August 2014
NCT01019707 Terminated Phase 1 Safety Assessment of Atomoxetine With MA IV Administration October 2009 December 2010
NCT01813656 Terminated Phase 4 An Study of Aripiprazole in the Treatment of Methamphetamine Dependence September 2012 February 2014
NCT00519259 Unknown status Phase 1 Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1 February 2006
NCT01273701 Unknown status N/A Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence January 2011 December 2012
NCT01044238 Unknown status Phase 2 Methylphenidate to Treat Methamphetamine Dependence October 2010 July 2014
NCT01919437 Unknown status N/A Comparison of Methamphetamine-Dependent and Healthy Volunteers Using a Web-Enabled Cognitive Neuropsychological Evaluation System April 2012 October 2013
NCT00439504 Unknown status Phase 1 Ph1 Lobeline Interaction Study - 1
NCT01601717 Withdrawn Phase 1 RTI-336 as a Treatment for Methamphetamine Dependence January 2010 January 2012
NCT00733967 Withdrawn Phase 1 Varenicline-Methamphetamine Interaction Study (2008) January 2008 August 2008
NCT00728312 Withdrawn Phase 4 Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial August 2009 April 2010